Drug Shortage Report for BRINEURA
Report ID | 222042 |
Drug Identification Number | 02484013 |
Brand name | BRINEURA |
Common or Proper name | CERLIPONASE ALFA INJECTION |
Company Name | BIOMARIN INTERNATIONAL LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CERLIPONASE ALFA |
Strength(s) | 150MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRACEREBROVENTRICULAR INTRACEREBROVENTRICULAR |
Packaging size | Each pack contains two vials, each containing 150 mg/5 ml cerliponase alfa, and one vial 5 ml of flushing solution |
ATC code | A16AB |
ATC description | |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2024-08-05 |
Actual start date | |
Estimated end date | |
Actual end date | 2024-05-21 |
Shortage status | Avoided shortage |
Updated date | 2024-08-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | SHANBALLY RINGASKIDDY, CORK IRELAND P43R298 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-08-28 | French | Compare |
v6 | 2024-08-28 | English | Compare |
v5 | 2024-08-06 | English | Compare |
v4 | 2024-03-13 | French | Compare |
v3 | 2024-03-13 | English | Compare |
v2 | 2024-03-13 | French | Compare |
v1 | 2024-03-13 | English | Compare |
Showing 1 to 7 of 7